Literature DB >> 1805140

[Relationship between virulence and resistance to antibiotics in pneumococci. Contribution of experimental data obtained in an animal model].

J P Bédos1, O Rolin, D H Bouanchaud, J J Pocidalo.   

Abstract

Epidemiologic data show that the organ affinity of Streptococcus pneumoniae varies across serotypes. As a result of this heterogeneous distribution, exposure to antimicrobials is greater for serotypes 6, 14, 19 and 23. Most strains with resistance to antimicrobials are found among these four serotypes. Virulence of the various serotypes of pneumococci varies with adhesion, enzyme secretion, and resistance to phagocytosis. In a mouse model of experimental septicemia, neither the origin of strains nor the acquisition of a resistant phenotype modified virulence, which appeared as an intrinsic feature specific to each phenotype. Strains belonging to serotypes 6, 14, 19 and 23 with or without resistance to antimicrobials were only very rarely virulent in the experimental model used. As an indirect result, resistance to antimicrobials and virulence were inversely related among the strains of S. pneumoniae tested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805140

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  9 in total

1.  Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice.

Authors:  E Azoulay-Dupuis; V Rieux; M Muffat-Joly; J P Bédos; E Vallée; C Rivier; R Isturiz; C Carbon; P Moine
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Authors:  J P Bédos; V Rieux; J Bauchet; M Muffat-Joly; C Carbon; E Azoulay-Dupuis
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 3.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

4.  Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.

Authors:  L Piroth; L Martin; A Coulon; C Lequeu; M Duong; M Buisson; H Portier; P Chavanet
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.

Authors:  J Gavaldà; J A Capdevila; B Almirante; J Otero; I Ruiz; M Laguarda; H Allende; E Crespo; C Pigrau; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

6.  Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.

Authors:  C Sauve; E Azoulay-Dupuis; P Moine; C Darras-Joly; V Rieux; C Carbon; J P Bédos
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

7.  Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.

Authors:  E Azoulay-Dupuis; P Moine; J P Bedos; V Rieux; E Vallee
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Authors:  P Moine; E Vallée; E Azoulay-Dupuis; P Bourget; J P Bédos; J Bauchet; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.

Authors:  E Azoulay-Dupuis; J Mohler; J P Bédos
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.